These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 7669719
1. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Turley JM, Funakoshi S, Ruscetti FW, Kasper J, Murphy WJ, Longo DL, Birchenall-Roberts MC. Cell Growth Differ; 1995 Jun; 6(6):655-63. PubMed ID: 7669719 [Abstract] [Full Text] [Related]
2. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Yu W, Heim K, Qian M, Simmons-Menchaca M, Sanders BG, Kline K. Nutr Cancer; 1997 Jun; 27(3):267-78. PubMed ID: 9101557 [Abstract] [Full Text] [Related]
3. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1. Yu W, Sanders BG, Kline K. Nutr Cancer; 2002 Jun; 43(2):227-36. PubMed ID: 12588702 [Abstract] [Full Text] [Related]
4. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, Kline K. Cancer Res; 1999 Feb 15; 59(4):953-61. PubMed ID: 10029090 [Abstract] [Full Text] [Related]
5. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells. Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, Heim K, Sanders BG, Kline K. Nutr Cancer; 1996 Feb 15; 26(2):237-50. PubMed ID: 8875561 [Abstract] [Full Text] [Related]
6. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ. Cancer Res; 1995 Jun 01; 55(11):2380-6. PubMed ID: 7757990 [Abstract] [Full Text] [Related]
7. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Turley JM, Falk LA, Ruscetti FW, Kasper JJ, Francomano T, Fu T, Bang OS, Birchenall-Roberts MC. Cell Growth Differ; 1996 Nov 01; 7(11):1535-44. PubMed ID: 8930403 [Abstract] [Full Text] [Related]
8. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Yu W, Sanders BG, Kline K. Cancer Res; 2003 May 15; 63(10):2483-91. PubMed ID: 12750270 [Abstract] [Full Text] [Related]
9. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Yu W, Sanders BG, Kline K. Nutr Cancer; 1997 May 15; 27(1):92-101. PubMed ID: 8970189 [Abstract] [Full Text] [Related]
10. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Turley JM, Fu T, Ruscetti FW, Mikovits JA, Bertolette DC, Birchenall-Roberts MC. Cancer Res; 1997 Mar 01; 57(5):881-90. PubMed ID: 9041190 [Abstract] [Full Text] [Related]
11. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate. Yu W, Sanders BG, Kline K. Nutr Cancer; 1996 Mar 01; 25(2):137-49. PubMed ID: 8710683 [Abstract] [Full Text] [Related]
13. RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells. Simmons-Menchaca M, Qian M, Yu W, Sanders BG, Kline K. Nutr Cancer; 1995 Mar 01; 24(2):171-85. PubMed ID: 8584453 [Abstract] [Full Text] [Related]
14. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate. Sing GK, Ruscetti FW, Beckwith M, Keller JR, Ellingsworth L, Urba WJ, Longo DL. Cell Growth Differ; 1990 Nov 01; 1(11):549-57. PubMed ID: 1965139 [Abstract] [Full Text] [Related]
15. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Yu W, Liao QY, Hantash FM, Sanders BG, Kline K. Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656 [Abstract] [Full Text] [Related]
16. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Zhao B, Yu W, Qian M, Simmons-Menchaca M, Brown P, Birrer MJ, Sanders BG, Kline K. Mol Carcinog; 1997 Jul 01; 19(3):180-90. PubMed ID: 9254885 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400 [Abstract] [Full Text] [Related]
18. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC. Cancer Res; 1997 Jul 01; 57(13):2668-75. PubMed ID: 9205075 [Abstract] [Full Text] [Related]
19. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. You H, Yu W, Sanders BG, Kline K. Cell Growth Differ; 2001 Sep 01; 12(9):471-80. PubMed ID: 11571230 [Abstract] [Full Text] [Related]
20. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. Yin Y, Ni J, Chen M, DiMaggio MA, Guo Y, Yeh S. Clin Cancer Res; 2007 Apr 01; 13(7):2271-80. PubMed ID: 17404112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]